Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 17 de 17
Filter
Add more filters










Publication year range
1.
Adv Exp Med Biol ; 994: 67-81, 2017.
Article in English | MEDLINE | ID: mdl-28560668

ABSTRACT

Cancer diagnostics and treatment monitoring rely on sensing and counting of rare cells such as cancer circulating tumor cells (CTCs) in blood. Many analytical techniques have been developed to reliably detect and quantify CTCs using unique physical shape and size of tumor cells and/or distinctive patterns of cell surface biomarkers. Main problems of CTC bioanalysis are in the small number of cells that are present in the circulation and heterogeneity of CTCs. In this chapter, we describe recent progress towards the selection and application of synthetic DNA or RNA aptamers to capture and detect CTCs in blood. Antibody-based approaches for cell isolation and purification are limited because of an antibody's negative effect on cell viability and purity. Aptamers transform cell isolation technology, because they bind and release cells on-demand. The unique feature of anti-CTC aptamers is that the aptamers are selected for cell surface biomarkers in their native state, and conformation without previous knowledge of their biomarkers. Once aptamers are produced, they can be used to identify CTC biomarkers using mass spectrometry. The biomarkers and corresponding aptamers can be exploited to improve cancer diagnostics and therapies .


Subject(s)
Aptamers, Nucleotide/chemistry , Biomarkers, Tumor/metabolism , Cell Separation/methods , Neoplasms/blood , Neoplastic Cells, Circulating/metabolism , Precision Medicine/methods , Humans , Neoplasms/diagnosis
2.
Mol Ther Nucleic Acids ; 6: 150-162, 2017 Mar 17.
Article in English | MEDLINE | ID: mdl-28325282

ABSTRACT

Nucleic acid aptamers are becoming popular as molecular probes for identification and imaging pathology and, at the same time, as a convenient platform for targeted therapy. Recent studies have shown that aptamers may be effectively used for tumor characterization and as commercially available monoclonal antibodies. Here we present three DNA aptamers binding to whole transformed lung cancer tissues, including tumor cells, connective tissues, and blood vessels. Protein targets have been revealed using affinity purification followed by mass spectrometry analyses, and they have been validated using a panel of correspondent antibodies and 3D imaging of tumor tissues. Each of the proteins targeted by the aptamers is involved in cancer progression and most of them are crucial for lung adenocarcinoma. We propose the use of these aptamers in aptahistochemistry for the characterization of the histological structure of lung adenocarcinoma. The value of the presented aptamers is their application together or separately for indicating the spread of neoplastic transformation, for complex differential diagnostics, and for targeted therapy of the tumor itself as well as all transformed structures of the adjacent tissues. Moreover, it has been demonstrated that these aptamers could be used for intraoperative tumor visualization and margin assessment.

3.
Nucleic Acid Ther ; 27(2): 105-114, 2017 04.
Article in English | MEDLINE | ID: mdl-27923103

ABSTRACT

Magnetomechanical cell disruption using nano- and microsized structures is a promising biomedical technology used for noninvasive elimination of diseased cells. It applies alternating magnetic field (AMF) for ferromagnetic microdisks making them oscillate and causing cell membrane disruption with cell death followed by apoptosis. In this study, we functionalized the magnetic microdisks with cell-binding DNA aptamers and guided the microdisks to recognize cancerous cells in a mouse tumor in vivo. Only 10 min of the treatment with a 100 Hz AMF was enough to eliminate cancer cells from a malignant tumor. Our results demonstrate a good perspective of using aptamer-modified magnetic microdisks for noninvasive microsurgery for tumors.


Subject(s)
Aptamers, Nucleotide/metabolism , Carcinoma, Ehrlich Tumor/therapy , Magnetic Field Therapy/methods , Magnetic Fields , Microsurgery/methods , Animals , Aptamers, Nucleotide/chemical synthesis , Carcinoma, Ehrlich Tumor/metabolism , Carcinoma, Ehrlich Tumor/pathology , Fibronectins/metabolism , Filamins/metabolism , Injections, Intralesional , Magnetic Field Therapy/instrumentation , Magnets , Male , Mice , Mice, Inbred ICR , Neoplasm Transplantation , Protein Binding , Sulfhydryl Compounds/chemistry
4.
Sci Rep ; 6: 34350, 2016 10 03.
Article in English | MEDLINE | ID: mdl-27694916

ABSTRACT

The development of an aptamer-based electrochemical sensor for lung cancer detection is presented in this work. A highly specific DNA-aptamer, LC-18, selected to postoperative lung cancer tissues was immobilized onto a gold microelectrode and electrochemical measurements were performed in a solution containing the redox marker ferrocyanide/ferricyanide. The aptamer protein targets were harvested from blood plasma of lung cancer patients by using streptavidin paramagnetic beads and square wave voltammetry of the samples was performed at various concentrations. In order to enhance the sensitivity of the aptasensor, silica-coated iron oxide magnetic beads grafted with hydrophobic C8 and C4 alkyl groups were used in a sandwich detection approach. Addition of hydrophobic beads increased the detection limit by 100 times. The detection limit of the LC-18 aptasensor was enhanced by the beads to 0.023 ng/mL. The formation of the aptamer - protein - bead sandwich on the electrode surface was visualized by electron microcopy. As a result, the electrochemical aptasensor was able to detect cancer-related targets in crude blood plasma of lung cancer patients.


Subject(s)
Aptamers, Nucleotide/metabolism , Biomarkers, Tumor/blood , Electrochemical Techniques/methods , Lung Neoplasms/blood , Neoplasm Proteins/blood , Female , Humans , Hydrophobic and Hydrophilic Interactions , Limit of Detection , Male , Microscopy, Electron
5.
Mol Ther ; 23(9): 1486-96, 2015 Sep.
Article in English | MEDLINE | ID: mdl-26061649

ABSTRACT

Circulating tumor cells (CTCs) are rare cells and valuable clinical markers of prognosis of metastasis formation and prediction of patient survival. Most CTC analyses are based on the antibody-based detection of a few epithelial markers; therefore miss an important portion of mesenchymal cancer cells circulating in blood. In this work, we selected and identified DNA aptamers as specific affinity probes that bind to lung adenocarcinoma cells derived from postoperative tissues. The unique feature of our selection strategy is that aptamers are produced for lung cancer cell biomarkers in their native state and conformation without previous knowledge of the biomarkers. The aptamers did not bind to normal lung cells and lymphocytes, and had very low affinity to A549 lung adenocarcinoma culture. We applied these aptamers to detect CTCs, apoptotic bodies, and microemboli in clinical samples of peripheral blood of lung cancer and metastatic lung cancer patients. We identified aptamer-associated protein biomarkers for lung cancer such as vimentin, annexin A2, annexin A5, histone 2B, neutrophil defensin, and clusterin. Tumor-specific aptamers can be produced for individual patients and synthesized many times during anticancer therapy, thereby opening up the possibility of personalized diagnostics.


Subject(s)
Adenocarcinoma/diagnosis , Adenocarcinoma/genetics , Aptamers, Nucleotide , Biomarkers, Tumor , Lung Neoplasms/diagnosis , Lung Neoplasms/genetics , Neoplastic Cells, Circulating/metabolism , Adenocarcinoma/metabolism , Adenocarcinoma/surgery , Adenocarcinoma of Lung , Aptamers, Nucleotide/chemistry , Carrier Proteins/metabolism , Cell Line , Humans , Lung Neoplasms/metabolism , Lung Neoplasms/surgery , Neoplasm Grading , Postoperative Period , Protein Binding , SELEX Aptamer Technique
6.
Biosens Bioelectron ; 67: 280-6, 2015 May 15.
Article in English | MEDLINE | ID: mdl-25190090

ABSTRACT

There is a widespread interest in the development of aptamer-based affinity chromatographic methods for purification of biomolecules. Regardless of the many advantages exhibited by aptamers when compared to other recognition elements, the lack of an efficient regeneration technique that can be generalized to all targets has encumbered further integration of aptamers into affinity-based purification methods. Here we offer switchable aptamers (SwAps) that have been developed to solve this problem and move aptamer-based chromatography forward. SwAps are controlled-affinity aptamers, which have been employed here to purify vesicular stomatitis virus (VSV) as a model case, however this technique can be extended to all biologically significant molecules. VSV is one oncolytic virus out of an arsenal of potential candidates shown to provide selective destruction of cancer cells both in vitro and in vivo. These SwAps were developed in the presence of Ca(2+) and Mg(2+) ions where they cannot bind to their target VSV in absence of these cations. Upon addition of EDTA and EGTA, the divalent cations were sequestered from the stabilized aptameric structure causing a conformational change and subsequently release of the virus. Both flow cytometry and electrochemical impedance spectroscopy were employed to estimate the binding affinities between the selected SwAps and VSV and to determine the coefficient of switching (CoS) upon elution. Among fifteen sequenced SwAps, four have exhibited high affinity to VSV and ability to switch upon elution and thus were further integrated into streptavidin-coated magnetic beads for purification of VSV.


Subject(s)
Aptamers, Nucleotide/chemistry , Biosensing Techniques , SELEX Aptamer Technique , Vesicular stomatitis Indiana virus/isolation & purification , Dielectric Spectroscopy , Humans , Oligonucleotides/chemistry , Streptavidin/chemistry , Vesicular stomatitis Indiana virus/chemistry , Vesicular stomatitis Indiana virus/genetics
7.
Rev Neurosci ; 26(2): 143-59, 2015.
Article in English | MEDLINE | ID: mdl-25528762

ABSTRACT

Neuroinflammation is as an important component of pathogenesis in many types of brain pathology. Immune mechanisms regulate neuroplasticity, memory formation, neurogenesis, behavior, brain development, cognitive functions, and brain metabolism. It is generally believed that essential homeostatic functions of astrocytes - astroglia-neuron metabolic coupling, gliovascular control, regulation of proliferation, and migration of cells in the neurogenic niches - are compromised in neuroinflammation resulting in excitotoxicity, neuronal and glial cell death, and alterations of intercellular communication. Viral neuroinfection, release of non-coding RNAs from the cells at the sites of brain injury or degeneration, and application of siRNA or RNA aptamers as therapeutic agents would require dsRNA-sensing pathways in the cells of neuronal and non-neuronal origin. In this review, we analyze the data regarding the role of astrocytes in dsRNA-initiated innate immune response in neuroinflammation and their contribution to progression of neurodegenerative and neurodevelopmental pathology.


Subject(s)
Astrocytes/metabolism , DNA/genetics , Neurodegenerative Diseases/metabolism , Signal Transduction , Toll-Like Receptor 3/metabolism , Animals , Astrocytes/cytology , Humans , Neurodegenerative Diseases/genetics , Neurogenesis , Toll-Like Receptor 3/genetics
8.
Mol Ther Nucleic Acids ; 3: e167, 2014 Jun 03.
Article in English | MEDLINE | ID: mdl-24892725

ABSTRACT

Oncolytic viruses promise to significantly improve current cancer treatments through their tumor-selective replication and multimodal attack against cancer cells. However, one of the biggest setbacks for oncolytic virus therapy is the intravenous delivery of the virus, as it can be cleared from the bloodstream by neutralizing antibodies before it reaches the tumor cells. We have selected DNA aptamers against an oncolytic virus, vesicular stomatitis virus, using a competitive binding approach, as well as against the antigen binding fragment (Fab) of antivesicular stomatitis virus polyclonal antibodies, in order to shield the virus from nAbs and enhance its in vivo survival. We used flow cytometry to identify these aptamers and evaluated their efficiency to shield vesicular stomatitis virus in a cell-based plaque forming assay. These oligonucleotides were then modified to obtain multivalent binders, which led to a decrease of viral aggregation, an increase in its infectivity and an increase in its stability in serum. The aptamers were also incubated in nondiluted serum, showing their effectiveness under conditions mimicking those in vivo. With this approach, we were able to increase viral infectivity by more than 70% in the presence of neutralizing antibodies. Thus, this method has the potential to enhance the delivery of vesicular stomatitis virus through the bloodstream without compromising the patient's immune system.

9.
Nucleic Acid Ther ; 24(2): 160-70, 2014 Apr.
Article in English | MEDLINE | ID: mdl-24410722

ABSTRACT

In recent years, new prospects for the use of nucleic acids as anticancer drugs have been discovered. Aptamers for intracellular targets can regulate cellular functions and cause cell death or proliferation. However, intracellular aptamers have limited use for therapeutic applications due to their low bioavailability. In this work, we selected DNA aptamers to cell organelles and nucleus of cancer cells, and showed that an aptamer NAS-24 binds to vimentin and causes apoptosis of mouse ascites adenocarcinoma cells in vitro and in vivo. To deliver the aptamer NAS-24 inside cells, natural polysaccharide arabinogalactan was used as a carrier reagent. The mixture of arabinogalactan and NAS-24 was injected intraperitonealy for 5 days into mice with adenocarcinoma and inhibited adenocarcinoma growth more effectively than free arabinogalactan or the aptamer alone. The use of aptamers to intracellular targets together with arabinogalactan becomes a promising approach for anticancer therapy.


Subject(s)
Adenocarcinoma/therapy , Aptamers, Nucleotide/genetics , Carcinoma, Ehrlich Tumor/therapy , Gene Expression Regulation, Neoplastic , Neoplasm Proteins/genetics , Vimentin/genetics , Adenocarcinoma/genetics , Adenocarcinoma/metabolism , Adenocarcinoma/pathology , Animals , Antineoplastic Agents/chemical synthesis , Antineoplastic Agents/metabolism , Apoptosis , Aptamers, Nucleotide/metabolism , Carcinoma, Ehrlich Tumor/genetics , Carcinoma, Ehrlich Tumor/metabolism , Carcinoma, Ehrlich Tumor/pathology , Cell Line, Tumor , Drug Carriers/chemistry , Drug Carriers/isolation & purification , Galactans/chemistry , Galactans/isolation & purification , Genetic Therapy , Hepatocytes/metabolism , Hepatocytes/pathology , Humans , Larix/chemistry , Liver/metabolism , Liver/pathology , Male , Mice , Mice, Inbred ICR , Molecular Targeted Therapy/methods , Neoplasm Proteins/antagonists & inhibitors , Neoplasm Proteins/metabolism , Vimentin/antagonists & inhibitors , Vimentin/metabolism
10.
J Med Chem ; 56(4): 1564-72, 2013 Feb 28.
Article in English | MEDLINE | ID: mdl-23387511

ABSTRACT

Salmonella is one of the most dangerous and common food-borne pathogens. The overuse of antibiotics for disease prevention has led to the development of multidrug resistant Salmonella. Now, more than ever, there is a need for new antimicrobial drugs to combat these resistant bacteria. Aptamers have grown in popularity since their discovery, and their properties make them attractive candidates for therapeutic use. In this work, we describe the selection of highly specific DNA aptamers to S. enteritidis and S. typhimurium. To evolve species-specific aptamers, twelve rounds of selection to live S. enteritidis and S. typhimurium were performed, alternating with a negative selection against a mixture of related pathogens. Studies have shown that synthetic pools combined from individual aptamers have the capacity to inhibit growth of S. enteritidis and S. typhimurium in bacterial cultures; this was the result of a decrease in their membrane potential.


Subject(s)
Anti-Bacterial Agents/chemical synthesis , Aptamers, Nucleotide/chemical synthesis , Salmonella enteritidis/drug effects , Salmonella typhimurium/drug effects , Anti-Bacterial Agents/chemistry , Anti-Bacterial Agents/pharmacology , Aptamers, Nucleotide/chemistry , Aptamers, Nucleotide/pharmacology , Base Sequence , Drug Resistance, Multiple, Bacterial , Molecular Sequence Data , SELEX Aptamer Technique , Structure-Activity Relationship
11.
Analyst ; 138(6): 1865-75, 2013 Mar 21.
Article in English | MEDLINE | ID: mdl-23381386

ABSTRACT

A novel attempt was made to develop a disposable multifunctional sensor for analysis of vaccinia virus (VACV), a promising oncolytic agent that can replicate in and kill tumor cells. Briefly, we developed aptamers specific to VACV that were negatively selected against human serum as well as human and mouse blood to be further utilized for viral analysis directly in serum and blood. In addition, the aptamers were negatively selected against heat-inactivated VACV to enable them to distinguish between viable and nonviable virus particles. The selected aptamers were integrated onto an electrochemical aptasensor to perform multiple functions, including quantification of VACV, viability assessment of the virus, and estimation of the binding affinity between the virus and the developed aptamers. The aptasensor was fabricated by self-assembling a hybrid of a thiolated ssDNA primer and a VACV-specific aptamer onto a gold nanoparticles modified screen-printed carbon electrode (GNPs-SPCE). Square wave voltammetry was employed to quantify VACV in serum and blood within the range of 150-900 PFU, with a detection limit of 60 PFU in 30 µL. According to the electrochemical affinity measurements, three virus specific aptamer clones, V-2, V-5, and V-9 exhibited the highest affinity to VACV. Furthermore, flow cytometry was employed to estimate the dissociation constants of the clones which were found to be 26.3, 40.9, and 24.7 nM, respectively. Finally, the developed aptasensor was able to distinguish between the intact virus and the heat-inactivated virus thanks to the tailored selectivity of the aptamers that was achieved via negative selection.


Subject(s)
Aptamers, Nucleotide/chemistry , Biosensing Techniques/methods , Blood/virology , Vaccinia virus/isolation & purification , Vaccinia/virology , Animals , Aptamers, Nucleotide/metabolism , Base Sequence , Electrochemical Techniques/methods , Humans , Limit of Detection , Mice , Microbial Viability , Vaccinia/blood , Vaccinia virus/physiology
12.
Anal Chem ; 84(21): 8966-9, 2012 Nov 06.
Article in English | MEDLINE | ID: mdl-23075417

ABSTRACT

The development of an aptamer-based viability impedimetric sensor for bacteria (AptaVISens-B) is presented. Highly specific DNA aptamers to live Salmonella typhimurium were selected via the cell-systematic evolution of ligands by exponential enrichment (SELEX) technique. Twelve rounds of selection were performed; each comprises a positive selection step against viable S. typhimurium and a negative selection step against heat killed S. typhimurium and a mixture of related pathogens, including Salmonella enteritidis, Escherichia coli, Staphylococcus aureus, Pseudomonas aeruginosa, and Citrobacter freundii to ensure the species specificity of the selected aptamers. The DNA sequence showing the highest binding affinity to the bacteria was further integrated into an impedimetric sensor via self-assembly onto a gold nanoparticle-modified screen-printed carbon electrode (GNP-SPCE). Remarkably, this aptasensor is highly selective and can successfully detect S. typhimurium down to 600 CFU mL(-1) (equivalent to 18 live cells in 30 µL of assay volume) and distinguish it from other Salmonella species, including S. enteritidis and S. choleraesuis. This report is envisaged to open a new venue for the aptamer-based viability sensing of a variety of microorganisms, particularly viable but nonculturable (VBNC) bacteria, using a rapid, economic, and label-free electrochemical platform.


Subject(s)
Aptamers, Nucleotide/metabolism , Bacteria/isolation & purification , Bacteria/metabolism , Biosensing Techniques/methods , Dielectric Spectroscopy , Microbial Viability , Bacteria/growth & development
13.
J Am Chem Soc ; 134(41): 17168-77, 2012 Oct 17.
Article in English | MEDLINE | ID: mdl-23016897

ABSTRACT

Oncolytic viruses are promising therapeutics that can selectively replicate in and kill tumor cells. However, repetitive administration of viruses provokes the generation of neutralizing antibodies (nAbs) that can diminish their anticancer effect. In this work, we selected DNA aptamers against the antigen binding fragment (Fab) of antivesicular stomatitis virus polyclonal antibodies to shield the virus from nAbs and enhance its in vivo survival. For the first time, we used flow cytometry and electrochemical immunosensing to identify aptamers targeting the Fab region of antibodies. We evaluated the aptamers in a cell-based infection assay and found that several aptamer clones provide more than 50% shielding of VSV from nAbs and thus have the potential to enhance the delivery of VSV without compromising the patient's immune system. In addition, we developed a bifunctional label-free electrochemical immunosensor for the quantitation of aptamer-mediated degree of shielding and the amount of vesicular stomatitis virus (VSV) particles. Electrochemical impedance spectroscopy was employed to interrogate the level of VSV in a linear range from 5 × 10(4) to 5 × 10(6) PFU mL(-1) with a detection limit of 10(4) PFU mL(-1).


Subject(s)
Antibodies, Neutralizing/chemistry , Aptamers, Nucleotide/chemistry , Vesiculovirus/chemistry , Antigen-Antibody Reactions , Electrochemical Techniques , Flow Cytometry , Molecular Structure
14.
Anal Chem ; 84(19): 8114-7, 2012 Oct 02.
Article in English | MEDLINE | ID: mdl-22971146

ABSTRACT

The development of an aptamer-based impedimetric sensor for typing of bacteria (AIST-B) is presented. Highly specific DNA aptamers to Salmonella enteritidis were selected via Cell-SELEX technique. Twelve rounds of selection were performed; each comprises a positive selection step against S. enteritidis and a negative selection step against a mixture of related pathogens, including Salmonella typhimurium, Escherichia coli, Staphylococcus aureus, Pseudomonas aeruginosa, and Citrobacter freundii, to ensure the species-specificity of the selected aptamers. After sequencing of the pool showing the highest binding affinity to S. enteritidis, a DNA sequence of high affinity to the bacteria was integrated into an impedimetric sensor via self-assembly onto a gold nanoparticles-modified screen-printed carbon electrode (GNPs-SPCE). Remarkably, this aptasensor is highly selective and can successfully detect S. enteritidis down to 600 CFU mL(-1) (equivalent to 18 CFU in 30 µL assay volume) in 10 min and distinguish it from other Salmonella species, including S. typhimurium and S. choleraesuis. This report is envisaged to open a new venue for the aptamer-based typing of a variety of microorganisms using a rapid, economic, and label-free electrochemical platform.


Subject(s)
Aptamers, Nucleotide/chemistry , Bacteria/isolation & purification , Biosensing Techniques , Biosensing Techniques/instrumentation
15.
Anal Chem ; 84(5): 2548-56, 2012 Mar 06.
Article in English | MEDLINE | ID: mdl-22324738

ABSTRACT

DNA aptamers are promising immunoshielding agents that could protect oncolytic viruses (OVs) from neutralizing antibodies (nAbs) and increase the efficiency of cancer treatment. In the present Article, we introduce a novel technology for electrochemical differentiation of epitope-specific aptamers (eDEA) without selecting aptamers against individual antigenic determinants. For this purpose, we selected DNA aptamers that can bind noncovalently to an intact oncolytic virus, vaccinia virus (VACV), which can selectively replicate in and kill only tumor cells. The aptamers were integrated as a recognition element into a multifunctional electrochemical aptasensor. The developed aptasensor was used for the linear quantification of the virus in the range of 500-3000 virus particles with a detection limit of 330 virions. Also, the aptasensor was employed to compare the binding affinities of aptamers to VACV and to estimate the degree of protection of VACV using the anti-L1R neutralizing antibody in a displacement assay fashion. Three anti-VACV aptamer clones, vac2, vac4, and vac6, showed the best immunoprotection results and can be applied for enhanced delivery of VACV. Another two sequences, vac5 and vac46, exhibited high affinities to VACV without shielding it from nAb and can be further utilized in sandwich bioassays.


Subject(s)
Aptamers, Nucleotide/metabolism , Electrochemical Techniques , Epitopes/metabolism , Antibodies, Neutralizing/immunology , Aptamers, Nucleotide/immunology , Epitopes/immunology , Fluorescent Dyes/chemistry , Humans , Oncolytic Viruses/immunology , Oncolytic Viruses/isolation & purification , Vaccinia virus/immunology , Vaccinia virus/isolation & purification
16.
Anal Chem ; 84(4): 1813-6, 2012 Feb 21.
Article in English | MEDLINE | ID: mdl-22303883

ABSTRACT

The development of aptamer-based viability impedimetric sensor for viruses (AptaVISens-V) is presented. Highly specific DNA aptamers to intact vaccinia virus were selected using cell-SELEX technique and integrated into impedimetric sensors via self-assembly onto a gold microelectrode. Remarkably, this aptasensor is highly selective and can successfully detect viable vaccinia virus particles (down to 60 virions in a microliter) and distinguish them from nonviable viruses in a label-free electrochemical assay format. It also opens a new venue for the development of a variety of viability sensors for detection of many microorganisms and spores.


Subject(s)
Aptamers, Nucleotide/chemistry , Aptamers, Nucleotide/genetics , Biosensing Techniques/methods , Gold/chemistry , Metal Nanoparticles/chemistry , Viruses/metabolism , Biosensing Techniques/instrumentation , Microelectrodes
17.
Anal Chem ; 84(3): 1677-86, 2012 Feb 07.
Article in English | MEDLINE | ID: mdl-22242920

ABSTRACT

Oncolytic viruses (OVs) are promising therapeutics that selectively replicate in and kill tumor cells. However, repetitive administration of OVs provokes the generation of neutralizing antibodies (nAbs) that can diminish their anticancer effects. In this work, we selected DNA aptamers against an oncolytic virus, vesicular stomatitis virus (VSV), to protect it from nAbs. A label-free electrochemical aptasensor was used to evaluate the degree of protection (DoP). The aptasensor was fabricated by self-assembling a hybrid of a thiolated ssDNA primer and a VSV-specific aptamer. Electrochemical impedance spectroscopy was employed to quantitate VSV in the range of 800-2200 PFU and a detection limit of 600 PFU. The aptasensor was also utilized for evaluating binding affinities between VSV and aptamer pools/clones. An electrochemical displacement assay was performed in the presence of nAbs and DoP values were calculated for several VSV-aptamer pools/clones. A parallel flow cytometric analysis confirmed the electrochemical results. Finally, four VSV-specific aptamer clones, ZMYK-20, ZMYK-22, ZMYK-23, and ZMYK-28, showed the highest protective properties with dissociation constants of 17, 8, 20, and 13 nM, respectively. Another four sequences, ZMYK-1, -21, -25, and -29, exhibited high affinities to VSV without protecting it from nAbs and can be further utilized in sandwich assays. Thus, ZMYK-22, -23, and -28 have the potential to allow efficient delivery of VSV through the bloodstream without compromising the patient's immune system.


Subject(s)
Aptamers, Nucleotide/chemistry , Biosensing Techniques/methods , Dielectric Spectroscopy , Vesicular stomatitis Indiana virus/chemistry , Antibodies, Neutralizing/immunology , Aptamers, Nucleotide/metabolism , Base Sequence , DNA, Single-Stranded/chemistry , Microelectrodes , Vesicular stomatitis Indiana virus/immunology , Vesicular stomatitis Indiana virus/metabolism
SELECTION OF CITATIONS
SEARCH DETAIL
...